Literature DB >> 26526420

When to consider an implantable cardioverter defibrillator following myocardial infarction?

Benjamin R Szwejkowski1, Gary A Wright2, Derek T Connelly2, Roy S Gardner2.   

Abstract

After reading this article the reader should be familiar with: Current guidelines for implantable cardioverter defibrillator (ICD) use post myocardial infarction (MI) and ischaemic cardiomyopathy. Primary prevention ICD guidelines. Secondary prevention ICD guidelines. Non-sustained ventricular tachycardia in patients post MI and the use of ICDs. Programming ICDs.

Entities:  

Mesh:

Year:  2015        PMID: 26526420     DOI: 10.1136/heartjnl-2015-307788

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  2 in total

1.  Implantable Cardioverter-defibrillator Therapy for Syncope: An Educational Example of a Multicomponent Electrocardiographic Differential Diagnosis and the Application of Clinical Trial Data to an Individual Patient.

Authors:  Daniel N Pugliese; James A Reiffel
Journal:  J Innov Card Rhythm Manag       Date:  2019-10-15

2.  Analysis of 24-h Rhythm in Ventricular Repolarization Identifies QT Diurnality As a Novel Clinical Parameter Associated with Previous Ventricular Arrhythmias in Heart Failure Patients.

Authors:  Bastiaan C Du Pre; Linda W Van Laake; Matthias Meine; Jeroen F Van der Heijden; Pieter A Doevendans; Marc A Vos; Toon A B Van Veen
Journal:  Front Physiol       Date:  2017-08-15       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.